193 related articles for article (PubMed ID: 27391317)
1. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
J Hematol Oncol; 2015 May; 8(1):57. PubMed ID: 27391317
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
J Hematol Oncol; 2015 May; 8():50. PubMed ID: 25966845
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
4. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
6. Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.
Huang D; Bi C; Zhao Q; Ding X; Bian C; Wang H; Wang T; Liu H
BMC Cancer; 2018 Sep; 18(1):919. PubMed ID: 30249208
[TBL] [Abstract][Full Text] [Related]
7. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.
Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL
Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression.
Nie FQ; Sun M; Yang JS; Xie M; Xu TP; Xia R; Liu YW; Liu XH; Zhang EB; Lu KH; Shu YQ
Mol Cancer Ther; 2015 Jan; 14(1):268-77. PubMed ID: 25504755
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
Huang Y; Xiang B; Liu Y; Wang Y; Kan H
Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing-related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR-199a-5p/SRSF1 axis and impacting Anillin.
Zhang Y; Lu Y; Wang N; Yang Y; Hao F; Fei X; Chen Y; Wang J
Mol Carcinog; 2024 Jun; 63(6):1064-1078. PubMed ID: 38411272
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
18. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144.
Ma Y; Zhang H; Li G; Hu J; Liu X; Lin L
Anticancer Drugs; 2019 Nov; 30(10):1013-1021. PubMed ID: 31609763
[TBL] [Abstract][Full Text] [Related]
19. lncRNA RBM5-AS1 promotes cell proliferation and invasion by epigenetically silencing miR-132/212 in hepatocellular carcinoma cells.
Mu JY; Tian JX; Chen YJ
Cell Biol Int; 2021 Nov; 45(11):2201-2210. PubMed ID: 34019714
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
